Nothing Special   »   [go: up one dir, main page]

ATE124044T1 - Carbonate des eserolins, ein verfahren zu deren herstellung und ihre verwendung als arzneimittel. - Google Patents

Carbonate des eserolins, ein verfahren zu deren herstellung und ihre verwendung als arzneimittel.

Info

Publication number
ATE124044T1
ATE124044T1 AT90105562T AT90105562T ATE124044T1 AT E124044 T1 ATE124044 T1 AT E124044T1 AT 90105562 T AT90105562 T AT 90105562T AT 90105562 T AT90105562 T AT 90105562T AT E124044 T1 ATE124044 T1 AT E124044T1
Authority
AT
Austria
Prior art keywords
eseroline
carbonates
production
medicinal product
chem
Prior art date
Application number
AT90105562T
Other languages
English (en)
Inventor
Edward J Glamkowski
Yulin Chiang
Barbara E Kurys
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Application granted granted Critical
Publication of ATE124044T1 publication Critical patent/ATE124044T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT90105562T 1989-03-27 1990-03-23 Carbonate des eserolins, ein verfahren zu deren herstellung und ihre verwendung als arzneimittel. ATE124044T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/329,171 US4971992A (en) 1989-03-27 1989-03-27 Carbonate derivatives of eseroline

Publications (1)

Publication Number Publication Date
ATE124044T1 true ATE124044T1 (de) 1995-07-15

Family

ID=23284183

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90105562T ATE124044T1 (de) 1989-03-27 1990-03-23 Carbonate des eserolins, ein verfahren zu deren herstellung und ihre verwendung als arzneimittel.

Country Status (18)

Country Link
US (1) US4971992A (de)
EP (1) EP0389984B1 (de)
JP (1) JPH0737458B2 (de)
KR (1) KR0163049B1 (de)
AT (1) ATE124044T1 (de)
AU (1) AU621208B2 (de)
CA (1) CA2013087C (de)
DE (1) DE69020205T2 (de)
DK (1) DK0389984T3 (de)
ES (1) ES2075081T3 (de)
FI (1) FI92932C (de)
HU (1) HU204053B (de)
IE (1) IE67449B1 (de)
IL (1) IL93895A (de)
NO (1) NO173995C (de)
NZ (1) NZ233065A (de)
PT (1) PT93535B (de)
ZA (1) ZA902307B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
US4914102A (en) * 1989-09-28 1990-04-03 Hoechst Roussel Pharmaceuticals, Inc. N-aminocarbamates related to physostigmine, pharmacentical compositions and use
US5077289A (en) * 1989-11-30 1991-12-31 Hoechst Roussel Pharmaceuticals Inc. Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine
US4983616A (en) * 1990-02-01 1991-01-08 Hoechst-Roussel Pharmaceuticals Inc. Hexahydropyrrolo(2,3-B)indole carbamates, ureas, amides and related compounds
AU634654B2 (en) * 1990-05-11 1993-02-25 Hoechst-Roussel Pharmaceuticals Incorporated Pyrrolo(2,3-b)indole-ketones and analogs, a process for their preparation and their use as medicaments
US5216017A (en) * 1990-05-11 1993-06-01 Hoechst-Roussel Pharmaceuticals Incorporated Pyrrolo[2,3-b]indole-ketones and analogs
AU634380B2 (en) * 1990-05-17 1993-02-18 Hoechst-Roussel Pharmaceuticals Incorporated Alpha-oxopyrrolo(2,3-b)indole acetic acids, esters, amides and related analogs, a process for their preparation and their use as medicaments
DE4139763A1 (de) * 1991-12-03 1993-06-09 Kali-Chemie Pharma Gmbh, 3000 Hannover, De Kristalline fumarsaure salze von 9,9-alkylen-3,7-diazabicyclononan-verbindungen und diese verbindungen enthaltende arzneimittel
US5409948A (en) * 1992-11-23 1995-04-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method for treating cognitive disorders with phenserine
AT404907B (de) * 1993-07-13 1999-03-25 Andritz Patentverwaltung Verfahren und anlage zum herstellen von edelstahlband
US5665880A (en) * 1996-10-31 1997-09-09 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseretholes
US5677457A (en) * 1996-12-19 1997-10-14 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseroline ethers
US20050182044A1 (en) * 2004-02-17 2005-08-18 Bruinsma Gosse B. Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate
CA2508585A1 (en) * 2004-06-01 2005-12-01 Axonyx, Inc. Transdermal delivery system for treatment of cognitive disorders
CA2509265A1 (en) * 2004-06-08 2005-12-08 Axonyx, Inc. Methods of delaying alzheimer's disease progression using a beta-amyloid precursor protein inhibitor and hmg coa reductase inhibitor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1109003B (it) * 1977-09-20 1985-12-16 Univ Firenze Derivati dell 1 2 3 8 3 a 8 a esai dropirrolo 23 b indolo
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
US4914102A (en) * 1989-09-28 1990-04-03 Hoechst Roussel Pharmaceuticals, Inc. N-aminocarbamates related to physostigmine, pharmacentical compositions and use
US5077289A (en) * 1989-11-30 1991-12-31 Hoechst Roussel Pharmaceuticals Inc. Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine

Also Published As

Publication number Publication date
JPH0737458B2 (ja) 1995-04-26
EP0389984A1 (de) 1990-10-03
FI92932B (fi) 1994-10-14
HUT54159A (en) 1991-01-28
NZ233065A (en) 1992-04-28
NO173995B (no) 1993-11-22
HU204053B (en) 1991-11-28
AU5220290A (en) 1990-11-08
KR900014388A (ko) 1990-10-23
AU621208B2 (en) 1992-03-05
CA2013087A1 (en) 1990-09-27
NO901385L (no) 1990-09-28
KR0163049B1 (ko) 1998-12-01
IL93895A0 (en) 1990-12-23
IE67449B1 (en) 1996-04-03
US4971992A (en) 1990-11-20
NO173995C (no) 1994-03-02
IE901097L (en) 1990-09-27
FI901470A0 (fi) 1990-03-23
HU901832D0 (en) 1990-08-28
IL93895A (en) 1995-07-31
DE69020205D1 (de) 1995-07-27
ZA902307B (en) 1990-12-28
FI92932C (fi) 1995-01-25
CA2013087C (en) 1999-12-28
PT93535B (pt) 1996-03-29
DK0389984T3 (da) 1995-10-30
NO901385D0 (no) 1990-03-26
EP0389984B1 (de) 1995-06-21
JPH02289572A (ja) 1990-11-29
DE69020205T2 (de) 1995-12-07
ES2075081T3 (es) 1995-10-01
PT93535A (pt) 1990-11-07

Similar Documents

Publication Publication Date Title
ATE124044T1 (de) Carbonate des eserolins, ein verfahren zu deren herstellung und ihre verwendung als arzneimittel.
ATE127807T1 (de) N-heteroaryl-purin-6-amine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
CA2029265A1 (en) 4- and 6-carbamates related to physostigmine, a process and intermediates for their preparation and their use as medicaments
ATE143020T1 (de) Aminocarbonylcarbamate verwandt mit physostigmin, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
HUT51597A (en) Process for production of derivatives of n,n-disubstituated diaryl-alcane-carbonic acid amid and medical compositions containing them as active substances
DE3872593D1 (de) 1-(n-(2-alkylthio-10h-phenothiazin-10-yl)alkyl)-4-benzoylpiperidine, ein verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee